M G Finn Selected Research

M G Finn Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 10/2007
8	Infections 01/2023 - 10/2008
3	COVID-19 12/2021 - 01/2021
3	Chagas Disease (American Trypanosomiasis) 01/2021 - 12/2016
3	Tobacco Use Disorder (Nicotine Dependence) 01/2017 - 03/2011
2	Melanoma (Melanoma, Malignant) 01/2024 - 10/2019
2	Parasitemia 01/2021 - 10/2020
2	Breast Neoplasms (Breast Cancer) 12/2018 - 01/2008
2	Leishmaniasis 09/2017 - 12/2016
2	Substance-Related Disorders (Drug Abuse) 07/2013 - 05/2011
1	Inflammation (Inflammations) 03/2024
1	Asthma (Bronchial Asthma) 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Hyperuricemia 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Human Influenza (Influenza) 01/2021
1	Wounds and Injuries (Trauma) 08/2020
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Vivax Malaria 01/2019
1	Visceral Leishmaniasis (Kala Azar) 09/2017
1	Cutaneous Leishmaniasis 09/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Hemolysis 01/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2017
1	Crohn Disease (Crohn's Disease) 01/2017
1	red meat allergy 03/2016
1	Tick Bites 03/2016
1	Anxiety Disorders (Anxiety Disorder) 10/2015
1	Mental Disorders (Mental Disorder) 10/2015
1	Pain (Aches) 07/2013
1	Leukemia 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2011
1	Hepatitis B 05/2008

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 01/2024 - 01/2013
10	AntibodiesIBA 10/2021 - 01/2008
8	AntigensIBA 01/2024 - 01/2008
6	Immunoglobulin G (IgG)IBA 01/2021 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2007
5	EpitopesIBA 10/2020 - 03/2016
5	CarbohydratesIBA 01/2019 - 01/2008
3	Polysaccharides (Glycans)IBA 01/2024 - 01/2008
3	CytokinesIBA 01/2021 - 08/2020
3	Nicotine FDA Link 01/2017 - 03/2011
2	Cancer VaccinesIBA 01/2024 - 01/2008
2	LectinsIBA 01/2024 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	Interleukin-12 (IL 12)IBA 01/2021 - 10/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 12/2016
2	Monoclonal AntibodiesIBA 01/2021 - 01/2017
2	Complement System Proteins (Complement)IBA 01/2017 - 01/2016
2	N- (bicyclo(2.2.1)hept- 2- yl)- 2- methyl- 5- (4- (trifluoromethyl)phenyl)- 4- pyrimidinamineIBA 01/2017 - 10/2015
2	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 10/2015 - 01/2013
2	Aminobutyrates (Aminobutyric Acid)IBA 10/2015 - 07/2013
2	GABA-B Receptor AgonistsIBA 05/2011 - 03/2011
2	GABA-B ReceptorsIBA 05/2011 - 03/2011
2	LigandsIBA 06/2010 - 10/2007
1	Histocompatibility Antigens Class IIIBA 03/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2024
1	Urate Oxidase (Uricase)IBA 01/2023
1	EnzymesIBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	Cell Adhesion MoleculesIBA 01/2022
1	OligonucleotidesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2020
1	HydrogelsIBA 08/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2020
1	Immunoglobulin M (IgM)IBA 01/2019
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 12/2018
1	Carrier Proteins (Binding Protein)IBA 12/2018
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2018
1	TrisaccharidesIBA 09/2017
1	GalactosyltransferasesIBA 09/2017
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2017
1	NucleotidesIBA 01/2017
1	Peptidoglycan (Murein)IBA 01/2017
1	eculizumab FDA Link 01/2017
1	Guanosine Triphosphate (GTP)IBA 01/2017
1	Complement C5 (Complement 5)IBA 01/2017
1	gamma-Aminobutyric Acid (GABA)IBA 01/2017
1	N,N'- dicyclopentyl- 2- methylsulfanyl- 5- nitro- pyrimidine- 4,6- diamineIBA 01/2017
1	benzonidazole (benznidazole)IBA 12/2016
1	Immunodominant EpitopesIBA 12/2016
1	Immunoglobulin E (IgE)IBA 03/2016
1	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2016
1	ThioureaIBA 01/2016
1	IntegrinsIBA 06/2012
1	Tyrosine (L-Tyrosine)FDA Link 06/2012
1	Phospholipases A2 (Phospholipase A2)IBA 06/2012
1	IronIBA 06/2010
1	Transferrin (beta 2 Transferrin)IBA 06/2010
1	Photosensitizing Agents (Photosensitizers)IBA 12/2009
1	Coloring Agents (Dyes)IBA 12/2009
1	Antiviral Agents (Antivirals)IBA 10/2008
1	His-His-His-His-His-His ((His)6)IBA 05/2008

Therapy/Procedure

5	Immunotherapy 01/2024 - 01/2008
5	Therapeutics 01/2023 - 12/2009
1	Self Administration (Administration, Self) 01/2017